3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid

This compound is a small molecule experimental drug belonging to the class of benzoic acids, characterized by a benzene ring with carboxylic acid functionality. It contains a dihydroxyboryl group attached to an (R)-configured chiral center linked to a (2-thienylacetyl)amino methyl substituent on the benzoic acid scaffold. The chemical formula is C14H14BNO5S with an average molecular weight of approximately 319.14 g/mol. It has been studied as an experimental agent and is known for its potential interaction with beta-lactamase enzymes, suggesting possible use in inhibiting these enzymes which are involved in bacterial resistance mechanisms. However, detailed mechanism of action and clinical indications are not well documented publicly. The compound was first registered around 2010 and remains classified as experimental without approved therapeutic uses or marketed brand names.[1][4][7]

Other names

3-[(R)-(dihydroxyboranyl)[2-(thiophen-2-yl)acetamido]methyl]benzoic acid(R)-3-(Borono(2-(thiophen-2-yl)acetamido)methyl)benzoic acid3-(Borono(2-(thiophen-2-yl)acetamido)methyl)benzoic acid